Press releases
Interim report July 1 – September 30, 2020
22 October, 2020By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. First Quarter Summary (July – September 2020) • Net sales amounted to MSEK 0.0 (0.0) • Operating […]
Report from the annual general meeting in DexTech Medical AB on 8 October 2020
8 October, 2020Today, October 8, 2020, the Annual General Meeting of DexTech Medical AB was held. Below is a summary of the decisions that were made. All decisions were made with the […]
DexTech Medical AB: Invitation to open Annual General Meeting and notice
8 September, 2020On Thursday, October 8, 2020, DexTech Medical AB (“DexTech”) will hold its Annual General Meeting. Subject to availability, non-shareholders are also welcome to participate without voting rights. At the meeting, […]
Dextech Medical AB Annual report 190701 – 200630
3 September, 2020Download annual report below. Dextech Annual report 190701-200630
Year-end report July 1, 2019 – June 30, 2020
28 August, 2020By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. Summary of the Fourth Quarter (April 1 – June 30, 2020) Net sales amounted to MSEK 0,0 […]
DexTech’s Phase IIb study for OsteoDex ends with positive follow-up results
12 June, 2020The company’s randomized Phase IIb study for the treatment of bone metastatic castration-resistant prostate cancer (mCRPC) has now been completed with 2-year follow-up results from the last patients. The primary […]
DexTech’s Phase IIb study for OsteoDex concludes with positive follow-up results
28 May, 2020The company’s Phase IIb study for the treatment of skeletal metastatic castration-resistant prostate cancer (mCRPC) shows continued promising follow-up data and confirms previously announced partial results. Formalities in the form […]
Interim report July 1, 2019 – March 31, 2020
6 May, 2020By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. Summary of the Nine-Month period (2019-07-01 – 2020-03-31) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss […]
Half Year report July 1 – December 31, 2019
31 January, 2020By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. Summary of the First Half Year (2019-07-01 – 2019-12-31) • Net sales amounted to MSEK 0.0 (0.0) […]
Interim report July 1 – September 30, 2019
24 October, 2019By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. First Quarter Summary (July – September 2019) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss […]